E-LIB Suche - Ergebnisse für: Wietek, N.

1

PO-1516 Quality of Life After Radical Treatment for Bladder..:

Appleyard, S. ; Wietek, N. ; Moynihan, C....
Radiotherapy and Oncology. 182 (2023) - p. S1232-S1233 , 2023

Link: https://doi.org/10.1016/..

2

Decision-making in Muscle Invasive Bladder Cancer – Patient..:

Appleyard, S. ; Wietek, N. ; Moynihan, C...
Clinical Oncology. 35 (2023) 2 - p. e235 , 2023

Link: https://doi.org/10.1016/..

3

A systematic review of observational management of cutaneou..:

Goodall, R ; Chicco, M ; Wietek, N...
Journal of Plastic, Reconstructive & Aesthetic Surgery. 75 (2022) 7 - p. 2277-2285 , 2022

Link: https://doi.org/10.1016/..

4

O045 A systematic review of observational management of cut..:

Goodall, R ; Chicco, M ; Wietek, N...
British Journal of Surgery. 109 (2022) Supplement_4 - p. , 2022

Link: https://doi.org/10.1093/..

5

Progeria syndrome in CKD/ESRD:

Power, A. ; Gill, D. ; Wietek, N....
Nephrology Dialysis Transplantation. 28 (2013) suppl 1 - p. i60-i60 , 2013

Link: https://doi.org/10.1093/..

6

Implementation of patient-reported outcome measures for gen..:

Kamran, R ; Jackman, L ; Chan, C...
doi:10.1001/jamanetworkopen.2023.6425. , 2023

Link: https://doi.org/10.1001/..

7

Single-cell transcriptomics identifies a WNT7A-FZD5 signali..:

Alsaadi, A ; Artibani, M ; Hu, Z...
doi:10.1016/j.celrep.2023.113354. , 2023

Link: https://doi.org/10.1016/..

8

Investigation of the potential mechanisms underlying nuclea..:

Wu, X ; Xing, X ; Wang, M...
doi:10.3389/fcell.2022.869531. , 2022

Link: https://doi.org/10.3389/..

9

Adipocyte-like signature in ovarian cancer minimal residual..:

Artibani, M ; Masuda, K ; Hu, Z...
doi:10.1172/jci.insight.147929. , 2021

Link: https://doi.org/10.1172/..

10

The Oxford Classic links epithelial-mesenchymal transition ..:

Hu, Z ; Cunnea, P ; Zhong, Z...
doi:10.1158/1078-0432.CCR-20-2782. , 2021

Link: https://doi.org/10.1158/..

11

Mechanistic drivers of Müllerian duct development and diffe..:

Santana Gonzalez, L ; Rota, IA ; Artibani, M...
doi:10.3389/fcell.2021.605301. , 2021

Link: https://doi.org/10.3389/..

12

Promises and challenges of adoptive T-cell therapies for so..:

Morotti, M ; Albukhari, A ; Alsaadi, A...
https://discovery.ucl.ac.uk/id/eprint/10126312/1/s41416-021-01353-6.pdf. , 2021

Link: https://discovery.ucl.ac..

13

Promises and challenges of adoptive T-cell therapies for so..:

Morotti, M ; Albukhari, A ; Alsaadi, A...
doi:10.1038/s41416-021-01353-6. , 2021

Link: https://doi.org/10.1038/..

14

The repertoire of serous ovarian cancer non-genetic heterog..:

Hu, Z ; Artibani, M ; Alsaadi, A...
doi:10.1016/j.ccell.2020.01.003. , 2020

Link: https://doi.org/10.1016/..

15

A dynamic CD2 rich compartment at the outer edge of the imm..:

Demetriou, P ; Abu-Shah, E ; Valvo, S...
doi:10.1038/s41590-020-0770-x. , 2020

Link: https://doi.org/10.1038/..